ADIPOQ and type 2 diabetes mellitus: Clinically, serum adiponectin concentrations are also inversely related to the risk of developing type II diabetes and cardiovascular disease, but directly related to decompensated congestive heart failure (CHF) [1,8,9,10,11,12,13].